Corundum Group Inc. grew its stake in U.S. Bancorp (NYSE:USB – Free Report) by 32.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,307 shares of the financial services provider’s stock after buying an additional 5,406 shares during […]
Corundum Group Inc. acquired a new stake in Devon Energy Co. (NYSE:DVN – Free Report) in the second quarter, Holdings Channel.com reports. The firm acquired 4,715 shares of the energy company’s stock, valued at approximately $228,000. Other large investors also recently modified their holdings of the company. T. Rowe Price Investment Management Inc. lifted its […]
Corundum Group Inc. purchased a new position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 1,466 shares of the medical research company’s stock, valued at approximately $206,000. A number of other institutional […]
Corundum Group Inc. lowered its position in shares of The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) by 34.9% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,664 shares of the investment management company’s stock after selling 1,426 shares during […]
Corundum Group Inc. decreased its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 42.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,841 shares of the biopharmaceutical company’s stock after selling 6,526 shares during the quarter. Corundum Group Inc.’s holdings in […]